Lirilumab (Anti-KIR)

製品コード：A2419         Batch: A241901

印刷

Lirilumab (Anti-KIR) is a  fully human monoclonal antibody against killer-cell immunoglobulin-like receptors (KIR), with potential antineoplastic activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research. MW: 150 kD.

製品説明

CAS No. 1000676-41-4
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Isotype Human IgG4SP
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions
Purity 99%
Protein concentration 5.665mg/ml
Endotoxin Level ＜1EU/mg

人間や獣医の診断であるか治療的な使用のためにでない。